Debridat



Indications and Reactions:

Role Indications Reactions
Primary
Peritonitis 66.7%
Hypothyroidism 33.3%
Convulsion 33.3%
Rash Morbilliform 33.3%
Surgery 33.3%
Secondary
Drug Use For Unknown Indication 29.1%
Drug Exposure During Pregnancy 21.8%
Product Used For Unknown Indication 14.0%
Hiv Infection 4.8%
Ill-defined Disorder 4.4%
Pyrexia 2.9%
Schizophrenia 2.9%
Pain 2.7%
Sigmoiditis 2.2%
Urinary Tract Infection 2.2%
Abdominal Pain 1.9%
Bipolar Disorder 1.9%
Leukaemia 1.5%
Constipation 1.2%
Diarrhoea 1.2%
Osteitis 1.2%
Thrombosis Prophylaxis 1.2%
Acute Myeloid Leukaemia 1.0%
Gastroenteritis 1.0%
Gastrointestinal Motility Disorder 1.0%
Cytolytic Hepatitis 9.2%
Weight Increased 9.2%
Renal Failure Acute 7.7%
Agranulocytosis 6.2%
Malaise 6.2%
Premature Baby 6.2%
Pyrexia 6.2%
Staphylococcal Infection 6.2%
Vomiting 6.2%
Thrombocytopenia 4.6%
Venous Insufficiency 4.6%
Drug-induced Liver Injury 3.1%
Hepatocellular Injury 3.1%
Hyperprolactinaemia 3.1%
Ileitis 3.1%
Premature Labour 3.1%
Rash Generalised 3.1%
Renal Failure 3.1%
Sinus Bradycardia 3.1%
Skin Exfoliation 3.1%
Concomitant
Drug Use For Unknown Indication 27.0%
Product Used For Unknown Indication 25.3%
Hypertension 4.7%
Pain 4.5%
Constipation 4.3%
Depression 3.5%
Abdominal Pain 3.3%
Crohn's Disease 3.2%
Renal Transplant 3.0%
Non-small Cell Lung Cancer 2.5%
Hepatitis C 2.3%
Anxiety 2.1%
Prophylaxis 2.1%
Epilepsy 2.0%
Unevaluable Event 1.9%
Chest Pain 1.8%
Osteoporosis 1.8%
Urinary Tract Infection 1.7%
Atrial Fibrillation 1.5%
Nausea 1.5%
Vomiting 12.1%
Somnolence 8.1%
Respiratory Distress 7.1%
Lung Disorder 6.1%
Rectal Haemorrhage 6.1%
Pneumonia Aspiration 5.1%
Renal Failure Acute 5.1%
Urticaria 5.1%
Cholestasis 4.0%
Cytolytic Hepatitis 4.0%
Haemolytic Anaemia 4.0%
Hyponatraemia 4.0%
Hypotension 4.0%
Pulmonary Embolism 4.0%
Sepsis 4.0%
Thrombocytopenia 4.0%
Weight Decreased 4.0%
Abdominal Pain 3.0%
Confusional State 3.0%
Hyperkalaemia 3.0%